AYA Conducts Successful Q-Submission Meeting with FDA
Filed with ASX · · 2 pages · English
Earlier from Artrya
- Artrya Lodges Key Submission in FDA Process
- Quarterly Activity Report and Appendix 4C-March 2023
- Board and Management Changes
- Appendix 4D and Half Year Financial Report
- Artrya Gains UK Regulatory Approval
Later from Artrya
- Company Presentation - MST Digital Health Forum
- Quarterly Activity Report and Appendix 4C-June 2023
- Appendix 4E and Annual Financial Report - 30 June 2023
- Quarterly Activity Report and Appendix 4C
- Response to ASX Query
Follow Artrya into a list and get an email when it puts out news.
Follow Artrya